Current Drug Targets

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Meet Our Editorial Board Member promotion: free to download

Volume:17   Issue:11
Pp: 1225-1225
Chen Chen
DOI: 10.2174/138945011711160729222826

Order Reprints Order Eprints

Editorial (Thematic Issue: Embryonic Signaling Pathways as Potential Targets for the Treatment of Rhabdomyosarcoma) free to download

Volume:17   Issue:11
Pp: 1226-1227
Soledad Gallego and Josep Roma
DOI: 10.2174/1389450117999160304150144

Order Reprints Order Eprints

Recent Insights into Notch Signaling in Embryonal Rhabdomyosarcoma

Volume:17   Issue:11
Pp: 1235-1244
Beatrice Conti, Katherine K. Slemmons, Rossella Rota and Corinne M. Linardic
DOI: 10.2174/1389450116666150907105756

Order Reprints Order Eprints

Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?

Volume:17   Issue:11
Pp: 1252-1264
Karly C. Sourris, Henry Yao, George Jerums, Mark E.Cooper, Elif I. Ekinci and Melinda T. Coughlan
DOI: 10.2174/1389450116666150722141418

Order Reprints Order Eprints

Substance P and its Inhibition in Ocular Inflammation

Volume:17   Issue:11
Pp: 1265-1274
Fabio Bignami, Paolo Rama and Giulio Ferrari
DOI: 10.2174/1389450116666151019100216

Order Reprints Order Eprints

Optimal Sequencing of New Drugs in Metastatic Castration-Resistant Prostate Cancer: Dream or Reality?

Volume:17   Issue:11
Pp: 1301-1308
Orazio Caffo, Andrea Lunardi, Chiara Trentin, Francesca Maines, Antonello Veccia and Enzo Galligioni
DOI: 10.2174/1389450117666160101121317

Order Reprints Order Eprints